Can patients with allergic purpura receive the influenza vaccine?
Sep 20, 2024
Source: Cainiu Health
Dr. Ren Yi
Introduction
If a patient with Henoch-Schönlein purpura (HSP) has their condition under control and is in a stable phase, influenza vaccination is generally acceptable. The flu vaccine can enhance the patient's immunity and reduce the risk of influenza-related complications. However, if the HSP patient is currently in the acute phase of the disease or has severe complications such as renal impairment or gastrointestinal bleeding, influenza vaccination is not recommended at that time.
Generally, if a patient with Henoch-Schönlein purpura (HSP) is in a stable condition, influenza vaccination is permissible. However, vaccination is not recommended during the acute phase of HSP or when severe complications are present.
If the condition of a patient with Henoch-Schönlein purpura has been well-controlled and the disease is in a stable phase, influenza vaccination is usually acceptable. The influenza vaccine helps prevent seasonal flu and can enhance the patient's immunity, thereby reducing the risk of flu-related complications.
Vaccination should be avoided if the patient is currently experiencing an acute episode of HSP or has serious complications such as renal impairment or gastrointestinal bleeding. During these periods, the patient's immune system is often compromised, and vaccination may exacerbate immune responses, potentially interfering with recovery.
In addition, patients with known allergies to any component of the influenza vaccine should not receive the vaccine, to prevent the risk of severe adverse reactions.
HSP patients should maintain healthy lifestyle habits before and after vaccination, including adequate rest, sufficient sleep, and avoiding excessive fatigue and emotional stress.
